2 completed. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow aIIV4: new trials by email Literature Review of aIIV4 trials Research Report on aIIV4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Simultaneous RZV and aIIV4 Vaccination FLUAD® Quadrivalent, Fluzone® High-Dose Quadrivalent, SHINGRIX® - Pain, Quality of Life | Phase 4 | Completed | Duke University | 267 | 2021-09-21 | 2024-07-11 |
| Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults Investigational aIIV4c, IIV4c, aIIV4 - Influenza, Human | Phase 2 | Completed | Seqirus | 471 | 2020-10-08 | 2024-04-17 |
Influenza, Human (2) · Drug-Related Side Effects and Adverse Reactions (1) · Injection Site Reaction (1) · Pain (1)
Duke University (1) · Seqirus (1)
United States (2)